Figures & data
Table 1. In-vitro evaluation of curcumin in-situ gel formulations containing 30% pluronic F127 and 1% carbopol P934, of pH 4 at zero time and after three months storage in refrigerator.
Figure 4. In-vitro release study of curcumin in-situ gel formulations: (a) without neutralization; (b) with neutralization.
![Figure 4. In-vitro release study of curcumin in-situ gel formulations: (a) without neutralization; (b) with neutralization.](/cms/asset/b7d5f1d5-3d21-4f69-a0dc-457a29d59890/idrd_a_1233591_f0004_c.jpg)
Table 2. Release Models for the selected formulation with and without neutralization.
Figure 5: Drug release profiles of Cur in-situ gel formulations subjected to a stability study in refrigerator, for 3 months. (a) G1 containing 1% suspended Cur formulation, (b) G2 containing 2% suspended Cur formulation, (c) G3 containing 1% dissolved Cur formulation and (d) G4 containing 2% dissolved Cur formulation.
![Figure 5: Drug release profiles of Cur in-situ gel formulations subjected to a stability study in refrigerator, for 3 months. (a) G1 containing 1% suspended Cur formulation, (b) G2 containing 2% suspended Cur formulation, (c) G3 containing 1% dissolved Cur formulation and (d) G4 containing 2% dissolved Cur formulation.](/cms/asset/f8e30005-b73d-42e4-adf2-60e93897b789/idrd_a_1233591_f0005_c.jpg)
Figure 6. Drug content of Cur in-situ gel formulations subjected to a stability study in refrigerator, for 3 months.
![Figure 6. Drug content of Cur in-situ gel formulations subjected to a stability study in refrigerator, for 3 months.](/cms/asset/65cc5bbf-fc75-4d81-8470-043e2b5c0ea0/idrd_a_1233591_f0006_c.jpg)